Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Beyond the typical immune effector cell-associated neurotoxicity syndrome: Characterizing non-immune effector cell-associated neurotoxicity syndrome neurological complications in chimeric antigen receptor T-cell therapy-A retrospective analysis.
Journal: Neuro-oncology advances
Published: February 09, 2026
Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial.
Journal: The Lancet. Oncology
Published: January 27, 2025
Leptomeningeal metastatic disease: new frontiers and future directions.
Journal: Nature reviews. Clinical oncology
Published: November 12, 2024
Correction: Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
Journal: Radiation oncology (London, England)
Published: May 15, 2024
Prolonged complete response to adjuvant tepotinib in a patient with newly diagnosed disseminated glioblastoma harboring mesenchymal-epithelial transition fusion.
Journal: The oncologist
Published: December 19, 2023
Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
Journal: Radiation oncology (London, England)
Published: August 10, 2023
Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells.
Journal: Haematologica
Published: April 06, 2023
Characterization of patients with brain metastases referred to palliative care.
Journal: BMC palliative care
Published: January 04, 2023
Casein Kinase 1 Epsilon Regulates Glioblastoma Cell Survival.
Journal: Scientific reports
Published: October 23, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026